Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT03554356 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT03554356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03554356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 4, 2018
Completion date
August 31, 2027
Enrollment
70 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal dysplasia, intestinal metaplasia